Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in sarcoma diagnostics and treatment
Amanda R. Dancsok, Karama Asleh, Torsten O. Nielsen
Oncotarget (2016) Vol. 8, Iss. 4, pp. 7068-7093
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations
Yoshiyuki Suehara, Deepu Alex, Anita S. Bowman, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 21, pp. 6346-6356
Open Access | Times Cited: 110
Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas
Amanda R. Dancsok, Nokitaka Setsu, Dongxia Gao, et al.
Modern Pathology (2019) Vol. 32, Iss. 12, pp. 1772-1785
Open Access | Times Cited: 76
SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT–receptor complex
Shujie Zhao, Y-Q Jiang, N-W Xu, et al.
Oncogene (2017) Vol. 37, Iss. 8, pp. 1049-1061
Open Access | Times Cited: 76
A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers
Michael J. Bollong, Mika Pietilä, Aaron D. Pearson, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 46
Open Access | Times Cited: 69
Sarcoma Spheroids and Organoids—Promising Tools in the Era of Personalized Medicine
Gianluca Colella, Flavio Fazioli, Michele Gallo, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 615-615
Open Access | Times Cited: 68
Sarcomas: Immune biomarker expression and checkpoint inhibitor trials
Mayanne M. T. Zhu, Elahe Shenasa, Torsten O. Nielsen
Cancer Treatment Reviews (2020) Vol. 91, pp. 102115-102115
Open Access | Times Cited: 57
Clinical and molecular insights into BCG immunotherapy for melanoma
Mirela Kremenovic, Mirjam Schenk, Delphine J. Lee
Journal of Internal Medicine (2020) Vol. 288, Iss. 6, pp. 625-640
Open Access | Times Cited: 52
Targeting the undruggable: exploiting neomorphic features of fusion oncoproteins in childhood sarcomas for innovative therapies
Maximilian M. L. Knott, Tilman L. B. Hölting, Shunya Ohmura, et al.
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 4, pp. 625-642
Open Access | Times Cited: 51
The opportunities and shortcomings of using big data and national databases for sarcoma research
Heather Lyu, Adil H. Haider, Adam Landman, et al.
Cancer (2019) Vol. 125, Iss. 17, pp. 2926-2934
Open Access | Times Cited: 49
Survival and prognostic factors following pulmonary metastasectomy for sarcoma
Giuseppe Marulli, Marco Mammana, Giovanni Maria Comacchio, et al.
Journal of Thoracic Disease (2017) Vol. 9, Iss. S12, pp. S1305-S1315
Open Access | Times Cited: 45
CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest
Ashleigh M. Francis, Angela Alexander, Yanna Liu, et al.
Molecular Cancer Therapeutics (2017) Vol. 16, Iss. 9, pp. 1751-1764
Open Access | Times Cited: 44
Three-Dimensional Patient-Derived In Vitro Sarcoma Models: Promising Tools for Improving Clinical Tumor Management
Manuela Gaebler, Alessandra Silvestri, Johannes Haybaeck, et al.
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 41
CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
Jordan L. Kohlmeyer, David J. Gordon, Munir R. Tanas, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3018-3018
Open Access | Times Cited: 35
Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis
Mariona Chicón‐Bosch, Sara Sánchez‐Serra, Marta Rosàs‐Lapeña, et al.
Molecular Oncology (2025)
Open Access
Therapeutic implications and comprehensive insights into cellular senescence and aging in the tumor microenvironment of sarcoma
Pengfei Zan, Yi Zhang, Yidong Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Exploring CX3CR1 as a prognostic biomarker and immunotherapeutic target in sarcoma
Tengfei Li, Xun Li, Pengcheng Kang, et al.
Translational Oncology (2025) Vol. 53, pp. 102283-102283
Open Access
Current status and future perspectives of immunotherapy for liposarcoma: From basic research to clinical practice
Aobo Zhuang, Zhe Xi, Ying Cheng, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 1, pp. 11-18
Closed Access
Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment
Zehao Cheng, Hua Wang, Y M Zhang, et al.
Cancer Letters (2025) Vol. 616, pp. 217585-217585
Closed Access
Current status and future perspectives of immunotherapy for abdominal liposarcoma: From basic research to clinical practice
Aobo Zhuang, Zhe Xi, Ying Cheng, et al.
Shijie huaren xiaohua zazhi (2025) Vol. 33, Iss. 2, pp. 81-88
Open Access
Modeling inter‐reader variability in clinical target volume delineation for soft tissue sarcomas using diffusion model
Yafei Dong, Thibault Marin, Yue Zhuo, et al.
Medical Physics (2025)
Closed Access
Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors
Matthew G. Pridgeon, Patrick J. Grohar, Matthew R. Steensma, et al.
Current Osteoporosis Reports (2017) Vol. 15, Iss. 4, pp. 239-246
Closed Access | Times Cited: 38
Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
Maria Letizia Taddei, Laura Pietrovito, Angela Leo, et al.
Cells (2020) Vol. 9, Iss. 2, pp. 510-510
Open Access | Times Cited: 32
Expression and Prognostic Value of MCM Family Genes in Osteosarcoma
Jian Zhou, Mingyong Wang, Zhen Zhou, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 27
NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression
Qizhi Qin, Mario Gomez-Salazar, Robert J. Tower, et al.
Cancer Research (2022) Vol. 82, Iss. 15, pp. 2734-2747
Open Access | Times Cited: 18
Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo
Rutulkumar Patel, Daniel E. Cooper, Kushal T. Kadakia, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top